bpc-157 thymosin Peptide Therapy And Bpc 157 bpc 157 thymosin beta 4

BCL2L1 and BCL2 are anti-apoptotic proteins belonging to the BCL2 family that function by preventing the oligomerization of the BAX and BAK proteins and maintaining the integrity of mitochondrial membrane, thus inhibiting cell apoptosis at high expression 37

Peptides are short chains of amino acids that act as natural messengers in the body

Animals were treated either locally on the site of the anastomosis by a bath of 1 ml of NaBPC157 (2 g/ml or 2 ng/ml), intragastrically or intraperitoneally (10 g or 10 ng/kg b.w.) immediately after anastomosis formation

Safety, Regulation, and FDA Status BPC-157 is not currently approved by the U.S